SAB Biotherapeutics Inc
(NAS:SABS)
$
3.77
-0.16 (-4.07%)
Market Cap: 288.27 Mil
Enterprise Value: 187.05 Mil
PE Ratio: 0
PB Ratio: 1.26
GF Score: 30/100 SAB Biotherapeutics Inc (SABS) Transcripts
- 1